QS Research · Michael Burry's Scion Capital analyst template · 2006
Cboe Global Markets, Inc. (CBOE)
As of 2026-11-21 · 12/15 boxes filled from SEC filings and market data
Report price $357.71 (close 2026-11-20)
Conclusion: PASS
Conviction low · base case -2% · downside -24% · upside +12%
The market is already paying for Cboe's quality: at $357.71 the stock carries 25.3x TTM net income to common of $1.47B, while 7.07x TTM sales sits above the 3.4x-5.6x five-year range. Cash conversion is strong and the franchise is licensed rather than easily replicated, but the price reflects that, and the only independent anchor available is a three-peer median, so conviction is limited. The downside case is -23.5% to $273.65 on a 10.0% earnings cut at a compressed P/E of 21.5x (today 25.3x). The base case is -1.6% to $352.05 on P/E at 24.9x, the peer median P/E across NDAQ 27.7x, ICE 22.9x and CME 24.9x. The upside case is +12.0% to $400.64 on +12% earnings at today's P/E of 25.3x. That spread does not offer an edge, so the call is PASS.
Key numbers
- Share price: $357.71
- Market cap: $37.32B
- Latest financial period: TTM to Sep 30, 2026
- Revenue (TTM): $5.28B
- P/E (TTM): 25.3x
- Price / book: 6.30x
- Earnings-quality flags (TTM): none flagged
- Revenue growth (latest fiscal year): +15.1%
The 15 boxes
- ✓ 1. Long-form business notes
Cboe Global Markets, Inc. (formerly CBOE Holdings, Inc. until 2017-10-13) is an exchange network earning transaction/clearing fees, market-data and access fees, index licensing and listings across options, North American equities, Europe/Asia Pacific, futures and global FX. FY2025 revenue was $4.71B with GAAP operating income of $1.47B and net income to common of $1.09B; the TTM to 2026-09-30 base is $5.28B revenue and $1.92B operating income, so valuation should sit on the current post-2025 portfolio, not the FY2020 base. Between the FY2020 and FY2025 10-Ks the segment set changed, with European Equities becoming Europe and Asia Pacific and Digital folded into Futures, while management wound down Japan, moved Australia/Canada to sale, exited corporate listings and cut ETP/CEDX/analytics costs.
- ✓ 2. Competitive advantage
The advantage is a licence and scale moat, not a cost moat: in 2025 about 68% of revenues less cost of revenues came from the options and futures segments, mostly products on exclusively licensed indices (SPX) and the proprietary VIX methodology, and revenue is 74% transaction- and clearing-based. The numbers bear that out: gross profit rose from $1.25B (FY2020) to $2.43B (FY2025) and $2.84B (TTM to Sep 2026), operating income from $662.2M to $1.47B and $1.92B, a roughly 36% TTM operating margin, on net income to common of $1.47B TTM against $5.93B total equity. Competition is severe and price-driven: as of December 31, 2025 four Cboe options exchanges face 14 other U.S. options exchanges (two more expected in the first half of 2026), and multi-listed options pricing has historically compressed net revenue per contract. The moat's weak point is contractual — the exclusive index and VIX licences can be lost or non-renewed.
- ✓ 3. 10-Q takeaways
Q3 2026 net revenue rose 18% to $712.2 million and organic net revenue rose 19% to $709.3 million, with increases in all revenue categories and Options net revenue up 23%. GAAP operating margin was 75.0%, but it included a $71.5 million Cboe Australia divestiture gain; adjusted operating margin was 71.4% and adjusted operating expenses fell to $204.0 million. Management raised 2026 organic revenue growth targets and cut adjusted operating expense guidance to $830-$845 million. The 10-Q reports no material risk-factor updates.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.